Butterfly Network to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference
Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld, whole-body ultrasound devices and software, announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference.
Joseph DeVivo, the company's President, CEO, and Chairman, will present and hold one-on-one investor meetings. The presentation is scheduled for June 12, 2024, at 10:00 am ET in Miami, Florida.
A live webcast will be available on Butterfly's investor website, with replays accessible post-event.
- Company's participation in a prestigious healthcare conference (Goldman Sachs 45th Annual Global Healthcare Conference).
- Opportunity for direct investor engagement through one-on-one meetings.
- Live webcast availability ensures broader access to the presentation.
- No new product announcements or financial updates were provided in the PR.
- Potential cost implications related to participating in high-profile conferences.
- Minor value to shareholders if no significant news or updates are shared.
June 12, 2024
A live webcast of the presentation will be available in the Events & Presentations section of the Butterfly investor website, and available for replay following the event.
To schedule a one-on-one meeting with Mr. DeVivo, please reach out to your Goldman Sachs representative.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission is to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of
View source version on businesswire.com: https://www.businesswire.com/news/home/20240528844030/en/
Butterfly Investors:
Heather Getz
Chief Financial and Operations Officers
investors@butterflynetwork.com
Source: Butterfly Network, Inc.
FAQ
When will Butterfly Network present at the Goldman Sachs 45th Annual Global Healthcare Conference?
Where can I watch the Butterfly Network presentation at the Goldman Sachs Conference?
What is the stock symbol for Butterfly Network?
Who will present on behalf of Butterfly Network at the Goldman Sachs Conference?
How can I schedule a one-on-one meeting with Butterfly Network's CEO at the Goldman Sachs Conference?
